“…IL‐8, 27 IL‐10, 27 IL‐18, 24 tumor necrosis factor‐alpha (TNF‐α), 13 interferon‐gamma (IFN‐γ), 13 transforming growth factor‐beta 1 (TGF‐β1), 13 intercellular adhesion molecule‐1 (ICAM‐1), 13 vascular adhesion molecule‐1 (VCAM‐1), 28 E‐selectin, 12 monocyte chemoattractant protein 1 (MCP‐1), 27 chemokine (C‐C motif) ligand 2 (CCL2), 27 growth factors granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) 29 and hepatocyte growth factor (HGF) 27 ; (3) Down‐regulation of nitric oxide (NO) hyperproduction : see Table 3; (4) Inhibition of the main local inflammatory mediators : by COX2 inhibition effect, it may inhibit prostaglandins, 12 prostacyclins, 12 histamine, 38 bradykinins 6,33,39 and NO 31 and (5) Antiangiogenic effect : by COX‐2 inhibition effect, it would negatively modulate vascular endothelial growth factor (VEGF), 40,42 basic fibroblast growth factor (bFGF), 40,42 CCL2, 27 HGF, 27 extracellular signal‐regulated kinase 2 (ERK2), 40 mitogen‐activated protein kinase (MAPK), 40 cyclin‐dependent kinase 1/2 (CDK 1/2), 40 checkpoint kinase 1 (CHK1), 40 cyclin A, 40 via Apelin/G protein‐coupled receptor (APJ) 40 and, by COX‐independent effect, NaIHS would inhibit hypoxia inducible factor‐1 alpha (HIF‐1α) 37 and HIF‐2α 43 . .…”